The development of cancer has been the subject of extensive research, with a total of 615 papers examining the effects of RIPK1, 119 papers investigating the effects of RIPK2, 550 papers exploring the effects of RIPK3, and 54 papers analyzing the effects of RIPK4 (Figure 2A-D). Here, RIPK2 is linked to cancer.